Is Saizen in shortage in 2026? Get the latest update on Saizen availability, pricing, alternatives, and what patients can do to get their prescription filled.
If you depend on Saizen for growth hormone therapy, you probably already know how frustrating it can be to fill your prescription. Between specialty pharmacy distribution, insurance hoops, and the eye-watering price tag, getting Saizen feels harder than it should be.
So is there an actual shortage? What's changed in 2026? And what can you do about it? Here's the latest.
As of early 2026, Saizen is not listed on the FDA's official drug shortage database. This means there is no formally reported manufacturing disruption or supply interruption from EMD Serono, the company that makes Saizen.
However, "not in shortage" and "easy to find" are two very different things. Many patients report difficulty getting Saizen filled at their pharmacy, and the reasons are structural rather than supply-based:
For a deeper dive into why this happens, read: Why is Saizen so hard to find?
Even without a formal shortage, several factors make Saizen difficult to access:
Saizen is a biologic medication produced through recombinant DNA technology using mammalian cell lines. This manufacturing process is far more complex than making a typical pill. Production takes weeks to months, and each batch must pass rigorous quality testing before release. Any disruption in this process can create temporary supply gaps.
Unlike medications you can grab at any corner drugstore, Saizen requires refrigerated storage and specialized handling. Retail pharmacies typically don't stock it. Instead, it flows through specialty pharmacy channels that manage ordering, cold-chain shipping, and patient support.
Growth hormone therapy is among the most heavily managed drug categories. Nearly every insurer requires prior authorization for Saizen, and many enforce step therapy — meaning your doctor may need to document why you specifically need Saizen rather than a preferred (often cheaper) alternative.
Several major insurance plans, including some UnitedHealthcare plans, have moved Saizen off their preferred drug lists. If your plan no longer covers Saizen as a preferred option, you may face higher costs or be required to try another brand first.
Saizen remains one of the more expensive growth hormone options:
With a GoodRx coupon, prices may start as low as $287 for certain formulations and pharmacies.
If cost is a barrier, check out our full savings guide: How to save money on Saizen in 2026.
The growth hormone therapy landscape has been evolving. Here are a few developments worth knowing about:
Newer long-acting growth hormone products like Sogroya (somapacitan) by Novo Nordisk and Skytrofa (lonapegsomatropin) by Ascendis Pharma offer once-weekly dosing instead of daily injections. These may be an option for patients and families looking for more convenience, though insurance coverage varies.
Omnitrope by Sandoz remains the primary biosimilar somatropin option and is often available at a lower price point than brand-name products like Saizen. If cost or availability is an issue, Omnitrope is worth discussing with your doctor.
For a full rundown of your options, read: Alternatives to Saizen.
If you're committed to staying on Saizen, here's how to improve your chances of getting it:
For detailed strategies, see: How to find Saizen in stock near you.
Saizen isn't technically in shortage in 2026, but that doesn't mean finding it is easy. The combination of specialty distribution, insurance restrictions, high costs, and formulary changes creates real barriers for patients who depend on it.
Stay proactive: use tools like Medfinder, work closely with your doctor and pharmacy, and explore all available savings programs. If Saizen truly isn't accessible, talk to your endocrinologist about switching to an equivalent somatropin product — the most important thing is staying on your therapy.
Know your medication inside and out: What is Saizen? Uses, dosage, and what you need to know.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
